The LPIN2 gene helps cells handle certain fats and keep inflammation under control. The protein made by this gene helps your cells stay balanced, especially in the immune system. If the LPIN2 gene is not working properly, it can cause Majeed syndrome, a rare inherited condition linked to repeated bone inflammation, low red blood cell levels from infancy or early childhood, and sometimes skin inflammation.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or manage activities in the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
LPIN2Gene function
What if the gene works
The LPIN2 gene helps cells make and manage fats that build membranes and store energy. It also helps keep inflammatory signals more controlled, especially in immune cells.
Risk
What if the gene does not work
People with harmful variants in the LPIN2 gene can develop Majeed syndrome, with recurring bone inflammation, anemia, and sometimes inflamed skin. Milder and more severe variants can influence when symptoms begin, how strong they are, and which features appear.
Treatment
What does that mean for your treatment
No the LPIN2 gene-specific treatment or drug-choice guideline is currently established. In LPIN2-related Majeed syndrome, IL-1 blocking medicines have shown benefit in published cases, so this pathway is a recognized treatment target under specialist care.
Conditions associated with LPIN2
Gene function
What if the gene works
Inside many cells, the LPIN2 gene helps manage how certain fats are processed and reused. Understanding LPIN2 gene function helps explain how cells build membranes, store energy, and keep fat signals in balance. When this gene is working normally, these everyday steps run smoothly in the background.
Its protein converts phosphatidic acid into diacylglycerol, two fats your cells use every day. This step helps direct fats toward storage and membrane production.
By making diacylglycerol available, lipin-2 supports the production of triglycerides, the main form of stored fat. This gives cells a way to save energy for later use.
This same fat pathway helps cells make phospholipids, which are major building blocks of cell membranes. That supports the outer layer of cells and the membranes inside them.
Phosphatidic acid and diacylglycerol also act as signals inside cells. Lipin-2 helps keep these fats in balance, which supports steady day to day cell activity.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the LPIN2 gene can lower the amount of lipin-2 protein, make it unstable, or sharply reduce its enzyme activity. In the LPIN2 gene, variants linked to Majeed syndrome may nearly eliminate protein function, disturb lipid handling inside cells, and overactivate the inflammasome (a cell alarm system that drives inflammation), while milder variants may leave some activity. This difference can influence how early symptoms appear and how pronounced they are.
How variants are linked to conditions
Pathogenic variants in the LPIN2 gene cause Majeed syndrome, a rare inherited condition. People with this diagnosis often have repeated episodes of bone inflammation in several areas, anemia from birth caused by unusual red blood cell development, and sometimes inflammatory skin problems. This makes LPIN2 variants linked to Majeed syndrome the main confirmed condition association for this gene.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LPIN2, risk is mainly shaped by genetics rather than lifestyle. A child’s chance of having an LPIN2-related condition is higher when both parents carry a harmful LPIN2 change, and risk can be greater in families where blood relatives have children together. There is not enough evidence to say that diet, exercise, or other daily habits lower this genetic risk.
Inheritance of LPIN2 variants
LPIN2-related disease is inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two disease-causing LPIN2 gene variants, one from each parent. Parents who each carry one LPIN2 gene variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variant. In practical terms, how LPIN2 gene variants are inherited is the same for sons and daughters.
What does my LPIN2 result mean for my family?
For LPIN2, family impact is usually discussed in terms of a recessive condition, which means close relatives may carry the same gene change even if they do not have symptoms. Brothers and sisters could also be affected or be carriers, and future children in the family could be affected if both parents carry an LPIN2 change. This can matter when relatives are thinking about family planning or learning more about an unexplained pattern of symptoms in the family.
Genetic information
Genetic testing
How you find out about variants
Variants in the LPIN2 gene are found with genetic testing, usually from a blood or saliva sample analyzed in a lab. Genetic testing for LPIN2 variants reads the gene’s DNA code to look for changes linked to conditions involving this gene and can help confirm whether a specific variant is present.
When should I consider getting a genetic test?
Genetic testing for the LPIN2 gene may be worth considering when someone has signs of Majeed syndrome, such as repeated bone inflammation, long-lasting bone pain, anemia, or a strong family history of this rare condition. It can also help clarify the cause when these problems start in childhood and routine testing has not given a clear answer.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains depends on the condition and the kind of variant involved. How your body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, or reacts to a drug, which helps explain why the same treatment works well for one person but less well for another. These differences are common and can influence both how much benefit a medicine provides and how sensitive someone may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body processes it. This information can help support better informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the LPIN2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response. If you have concerns about side effects, new symptoms, or how your medicines may affect you, talk with your doctor or pharmacist.
History
In recent decades, awareness of the LPIN2 gene’s role has grown. LPIN2 was identified in the early 2000s as part of the lipin gene family, after earlier work on related genes helped researchers map this group more clearly. A major milestone came in 2005, when variants in the LPIN2 gene were linked to Majeed syndrome, a rare inherited condition first recognized through affected families. This connection gave doctors a clearer genetic explanation for a pattern of long lasting bone inflammation, anemia, and skin symptoms that had been difficult to classify. From these first observations, research expanded steadily. Over time, descriptions became more precise, and LPIN2 moved from being a newly cataloged gene to one with a recognized place in rare disease genetics.